InSphero and PharmaNest: Partnership to advance translational fibrosis research
InSphero partnered with PharmaNest to combine 3D liver spheroids, high-resolution single-fiber digital pathology, and AI for quantitative fibrosis phenotyping and translational antifibrotic drug screening.
Why it mattersPharmaNest's single-fiber digital pathology integrated with InSphero liver spheroids lets drug teams de-risk antifibrotic candidates earlier.